Main > HEPATOLOGY > Hepatitis C Virus Infection > Treatment > Co: USA. A. Glecaprevir+*

---

Co: USA. A. Glecaprevir+*'s subsections
(*) CA Approval Date: 2017. 08.17
(*) EU Approval Date: 2017. 07.28
(*) JP Approval Date: 2017. 09.27
(*) USA Approval Date: 2017. 08.03
+Pibrentasvir
Company
Patent>Assignee
TradeMark

Co: USA. A. Glecaprevir+*'s products
This section has no products